Table 1. Summary results for SNPs associated with CLL risk.
SNP | Locus | Position (bp, hg19) | Risk allele | Data set | RAF (case; control) | OR | 95% CI | P value |
---|---|---|---|---|---|---|---|---|
rs34676223 | 1p36.11 | 23943735 | C | Discovery | (0.74; 0.71) | 1.16 | (1.09; 1.22) | 2.69 × 10−7 |
Replication | (0.74; 0.69) | 1.29 | (1.18; 1.42) | 4.69 × 10−8 | ||||
Combined | 1.19 | (1.14; 1.25) | 5.04 × 10−13 | |||||
I2=24% | Phet=0.23 | |||||||
rs41271473 | 1q42.13 | 228880296 | G | Discovery | (0.81; 0.79) | 1.19 | (1.12; 1.26) | 4.69 × 10−8 |
Replication | (0.82; 0.79) | 1.20 | (1.08; 1.34) | 5.59 × 10−4 | ||||
Combined | 1.19 | (1.13; 1.26) | 1.06 × 10−10 | |||||
I2=0% | Phet=0.95 | |||||||
rs71597109 | 4q24 | 102741002 | C | Discovery | (0.72; 0.69) | 1.17 | (1.11; 1.24) | 1.02 × 10−8 |
Replication | (0.73; 0.71) | 1.15 | (1.05; 1.26) | 3.46 × 10−3 | ||||
Combined | 1.17 | (1.11; 1.22) | 1.37 × 10−10 | |||||
I2=0% | Phet=0.78 | |||||||
rs57214277 | 4q35.1 | 185254772 | T | Discovery | (0.44; 0.41) | 1.14 | (1.08; 1.19) | 9.56 × 10−7 |
Replication | (0.43; 0.39) | 1.12 | (1.03; 1.21) | 0.011 | ||||
Combined | 1.13 | (1.08; 1.18) | 3.69 × 10−8 | |||||
I2=0% | Phet=0.53 | |||||||
rs3800461 | 6p21.31 | 34616322 | C | Discovery | (0.13; 0.11) | 1.21 | (1.12; 1.31) | 4.20 × 10−7 |
Replication | (0.12; 0.11) | 1.17 | (1.03; 1.34) | 0.014 | ||||
Combined | 1.20 | (1.13; 1.28) | 1.97 × 10−8 | |||||
I2=0% | Phet=0.69 | |||||||
rs61904987 | 11q23.2 | 113517203 | T | Discovery | (0.14; 0.12) | 1.23 | (1.14; 1.32) | 4.44 × 10−8 |
Replication | (0.13; 0.12) | 1.26 | (1.12; 1.42) | 1.20 × 10−4 | ||||
Combined | 1.24 | (1.16; 1.32) | 2.46 × 10−11 | |||||
I2=0% | Phet=0.83 | |||||||
rs1036935 | 18q21.1 | 47843534 | A | Discovery | (0.25; 0.22) | 1.17 | (1.10; 1.24) | 2.81 × 10−7 |
Replication | (0.24; 0.22) | 1.11 | (1.01; 1.23) | 0.028 | ||||
Combined | 1.15 | (1.10; 1.21) | 3.27 × 10−8 | |||||
I2=0% | Phet=0.65 | |||||||
rs7254272 | 19p13.3 | 4069119 | A | Discovery | (0.20; 0.18) | 1.18 | (1.11; 1.26) | 4.61 × 10−7 |
Replication | (0.19; 0.18) | 1.13 | (1.01; 1.26) | 0.026 | ||||
Combined | 1.17 | (1.10; 1.23) | 4.67 × 10−8 | |||||
I2=0% | Phet=0.55 | |||||||
rs140522 | 22q13.33 | 50971266 | T | Discovery | (0.35; 0.32) | 1.16 | (1.10; 1.22) | 2.20 × 10−8 |
Replication | (0.35; 0.33) | 1.10 | (1.01; 1.2) | 0.025 | ||||
Combined | 1.15 | (1.10; 1.20) | 2.70 × 10−9 | |||||
I2=0% | Phet=0.94 |
bp, base pair position; CLL, chronic lymphocytic leukaemia; I2, proportion of the total variation due to heterogeneity; OR, odds ratio; Phet, P-value for heterogeneity; RAF, risk allele frequency; SNP, single-nucleotide polymorphism; 95% CI, 95% confidence interval.
RAF is risk allele frequency across all of the discovery and replication data sets, respectively. ORs are derived with respect to the risk allele. Text in bold highlight the P-value in the combined data.